Position in MOLN
as of Jun 30, 2026
· filed Aug 14, 2026
Position Value
$8,597,181
-$219,928 QoQ
Shares Held
2,221,494
0.0% QoQ
Ownership
5.80%
of shares outstanding
% of Portfolio
0.18%
of 13F equity value
Holder Rank
#1
of 5 holders
Holding Since
Jun 2021
21 quarters on record
Voting authority
Sole 100%
Shared 0%
None 0%
Common Shares in MOLN Over Time
Shares Held
Position Value (USD)
Position in Biotechnology
Healthcare · as of Jun 30, 2026SUVRETTA CAPITAL MANAGEMENT, LLC holds $2,923,514,073 across 34 Biotechnology names. MOLN ranks #28 (0.3% of the industry book) .
| # | Ticker | Company | Shares | Value (USD) | Open |
|---|---|---|---|---|---|
| 1 | MANE |
Veradermics, Inc
|
4,168,970 | $512,533,171 | |
| 2 | ARQT |
Arcutis Biotherapeutics, Inc.
|
12,437,000 | $326,098,140 | |
| 3 | LEGN |
Legend Biotech Corp
|
7,070,000 | $204,181,600 | |
| 4 | PVLA |
Palvella Therapeutics, Inc.
|
1,135,406 | $173,512,744 | |
| 5 | AVBP |
ArriVent BioPharma, Inc.
|
4,515,531 | $156,869,546 | |
| 6 | BNTC |
Benitec Biopharma Inc.
|
11,548,351 | $154,516,936 | |
| 7 | BHVN |
Biohaven Ltd.
|
10,286,937 | $153,069,622 | |
| 8 | RCUS |
Arcus Biosciences, Inc.
|
4,776,423 | $147,257,121 |
All Filings in MOLN
Export CSV
21 filing rows on record
| Report Date | Value (USD) | Shares | Type | Discretion | Filed | |
|---|---|---|---|---|---|---|
| 2026-06-30 | $8,597,181 | 2,221,494 | Shares | Sole | 2026-08-14 | |
| 2026-03-31 | $8,817,109 | 2,221,494 | Shares | Sole | 2026-05-15 | |
| 2025-12-31 | $9,683,492 | 2,221,494 | Shares | Sole | 2026-02-17 | |
| 2025-09-30 | $8,241,742 | 2,221,494 | Shares | Sole | 2025-11-14 | |
| 2025-06-30 | $8,486,107 | 2,221,494 | Shares | Sole | 2025-08-14 | |
| 2025-03-31 | $8,619,396 | 2,221,494 | Shares | Sole | 2025-05-15 | |
| 2024-12-31 | $10,547,653 | 2,221,494 | Shares | Sole | 2025-02-14 | |
| 2024-09-30 | $2,034,800 | 400,000 | Shares | Sole | 2024-11-14 | |
| 2024-06-30 | $2,892,000 | 400,000 | Shares | Sole | 2024-08-14 | |
| 2024-03-31 | $1,680,000 | 400,000 | Shares | Sole | 2024-05-15 | |
| 2023-12-31 | $1,672,000 | 400,000 | Shares | Sole | 2024-02-14 | |
| 2023-09-30 | $1,656,000 | 400,000 | Shares | Sole | 2023-11-14 | |
| 2023-06-30 | $2,488,000 | 400,000 | Shares | Sole | 2023-08-14 | |
| 2023-03-31 | $2,415,200 | 400,000 | Shares | Sole | 2023-05-15 | |
| 2022-12-31 | $2,620,000 | 400,000 | Shares | Sole | 2023-02-14 | |
| 2022-09-30 | $2,676,000 | 400,000 | Shares | Sole | 2022-11-14 | |
| 2022-06-30 | $2,712,000 | 400,000 | Shares | Sole | 2022-08-15 | |
| 2022-03-31 | $8,220,000 | 400,000 | Shares | Sole | 2022-05-16 | |
| 2021-12-31 | $7,672,000 | 400,000 | Shares | Sole | 2022-02-14 | |
| 2021-09-30 | $7,844,000 | 400,000 | Shares | Sole | 2021-11-16 | |
| 2021-06-30 | $8,196,000 | 400,000 | Shares | Sole | 2021-08-16 | |
| No filing history on record for this holder in this stock. | ||||||